Overview Fundamentals API Earnings EOD API Sample Code Pricing

Iteos Therapeutics Inc (ITOS NASDAQ) stock market data APIs

$16.31 0.05(0.3%) as of July 23, 2024
Price chart is built with Anychart

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer. The company's lead antibody product candidate, belrestotug, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial, as well as used to engage the Fc gamma receptor, or Fc"R to activate dendritic cells, natural killer cells, and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Its product pipeline also includes inupadenant, a next-generation A2AR antagonists that is in Phase 1/2a clinical trials to overcome the specific adenosine-mediated immunosuppression found in tumor microenvironment; and EOS-984, a small molecule targeting equilibrative nucleoside transporter 1 (ENT1) to inhibit the immunosuppressive activity of adenosine and restore immune cell proliferation is in Phase 1 clinical trials. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts.

Iteos Therapeutics Inc Financial Data Overview

16.26
16.31
-
16.67
16.17
8.2-18.75
596 M
36 123 K
0
-1.07
1.398
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ITOS',
Type: 'Common Stock',
Name: 'Iteos Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00VPNFSJ5',
ISIN: NULL,
CUSIP: NULL,
CIK: '1808865',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2020-07-24',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Iteos Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -168 436 992
  • Earnings Per Share -3.78
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Iteos Therapeutics Inc Earnings via APIs

  • Latest Release 2024-05-10
  • EPS/Forecast -1.26

Get Iteos Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com